DNL.L Share News (DNL)

DNL.L Information

There is currently no data for DNL

UK Shareholder Meetings Calendar - Next 7 Days

Fri, 13th Nov 2020 16:06

Monday 16 November
Smiths Group PLC	AGM
JPMorgan Brazil Investment Trust PLC	GM re liquidation of company
European Opportunities Trust PLC	AGM
Tuesday 17 November
Dunelm Group PLC	AGM
BMO Real Estate Investments Ltd	AGM
Mulberry Group PLC	AGM
Scancell Holdings PLC	AGM
Physiomics PLC	AGM
Marwyn Value Investors Ltd	AGM
Craneware PLC	AGM
Shaftesbury PLC	GM re share issue resolutions
SIG PLC	GM re new remuneration policy
Wednesday 18 November
Beeks Financial Cloud Group PLC	AGM
Henderson Eurotrust PLC	AGM
Exillon Energy PLC	EGM re stock listing cancellation
Avingtrans PLC	AGM
Rainbow Rare Earths Ltd	AGM
Origin Enterprises PLC	AGM
Countrywide PLC	GM re proposed recapitalisation
Thursday 19 November
Close Brothers Group PLC	AGM
FW Thorpe PLC	AGM
William Hill PLC	GM re acquisition by Caesars Group
Jupiter UK Growth Investment Trust PLC	AGM
Finsbury Food Group PLC	AGM
Maestrano Group PLC	AGM
Randall & Quilter Investment Holdings Ltd	GM - re capital return
Infrastructure India PLC	AGM
Gresham House Energy Storage Fund PLC	GM re share issue, changes to investment policy
Friday 20 November
Salt Lake Potash Ltd	AGM
Diurnal Group PLC	AGM
Go-Ahead Group PLC	AGM
MC Mining Ltd	AGM
GSTechnologies Ltd	AGM
Gulf Investment Fund PLC	AGM

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

10 Jan 2019 11:33

Diurnal Shares Surge As Secures Second Patent For Chronocort In US

LONDON (Alliance News) - Diurnal Group PLC on Thursday said the US Patent & Trademark Office has granted the company a second US patent for Chronocort.Diurnal shares almost tripled on a

10 Jan 2019 11:26

Diurnal awarded US patent for Chronocort product

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Thursday that the US Patent and Trademark Office (USPTO) has granted a second US patent for its 'Chronocort' modified release hydrocortisone product.

17 Oct 2018 12:10

Diurnal halts US development of Chronocort after European trials come up short

(Sharecast News) - Speciality pharmaceutical company Diurnal has put all development activities for its modified release hydrocortisone product on hold after it failed to meet its primary endpoint in a recent phase-three European trial.

17 Oct 2018 10:41

Diurnal Puts All Chronocort US Development Activities On Hold

LONDON (Alliance News) - Diurnal Group PLC said Wednesday it decided to put all US development activities for its Chronocort product on hold, after it failed to meet its primary objective in its a

8 Oct 2018 17:07

LONDON MARKET CLOSE: Stocks End Lower On Chinese And Italian Woes

LONDON (Alliance News) - Stocks closed lower Monday on the actions of the Chinese and Italian governments, as the pound continued its fall on news from 10 Downing Street there remains "big in of

8 Oct 2018 15:15

Diurnal Group Child Adrenal Insufficiency Drug Approved In Scotland

LONDON (Alliance News) - Diurnal Group PLC said Monday the Scottish Medicines Consortium approved the routine use of Alkindi, a first-line treatment of young children with adrenal insufficiency to

8 Oct 2018 12:00

LONDON MARKET MIDDAY: China Prompts Sell-Off In Europe; Insurers Fall

LONDON (Alliance News) - Share prices in London had slipped firmly into the red by midday on Monday following a slump in Chinese equities overnight."Europe is following the Asian lead, with a 3%

8 Oct 2018 10:33

WINNERS & LOSERS SUMMARY: French Connection In Vogue On Possible Sale

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 1.0%. The asset manager confirmed it is in to

8 Oct 2018 09:29

Diurnal's endocrine drug does not meet trial objective

(Sharecast News) - Clinical trials of Diurnal Group's Chronocort drug failed to meet the primary objective of proving superior to conventional therapy in endocrine control over a 24-hour period.

8 Oct 2018 08:54

Shares In IP Group, Diurnal Suffer After Chronocort Trial Disappoints

LONDON (Alliance News) - Diurnal Group PLC said Monday its phase-three European trial of Chronocort did not meet its primary objective, causing shares in the pharmaceutical company to property IP

8 Oct 2018 07:48

LONDON MARKET PRE-OPEN: Lower Call; Schroders Confirms Lloyds Talks

LONDON (Alliance News) - Stocks in London on Monday are set to continue last week's slide, fuelled by concerns that strong US economic data will lead to a quickened pace of interest rate hikes.In

5 Oct 2018 09:20

Diurnal kicks off adrenal condition trial with first patients

(Sharecast News) - Specialist pharmaceutical company Diurnal said it had enrolled the first two patients in its US-based Chronocort phase III trial for adults with congenital adrenal hyperplasia (CAH).

5 Oct 2018 08:16

Diurnal Enrols First Patients In Phase Three US Chronocort Trial

LONDON (Alliance News) - Pharmaceutical company Diurnal Group PLC on Friday said the first two patients have been enrolled into its phase three US trial of Chronocort.Chronocort is a form a

20 Sep 2018 09:56

Diurnal Generates First Revenue But Loss Deepens As Costs Rise

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Thursday its annual loss deepened amid higher costs despite generating its first revenue from drug sales.For the year the

15 Aug 2018 12:39

German Body Says Diurnal Alkindi's Benefit Over Generic Not Proven

LONDON (Alliance News) - Diurnal Group PLC said Wednesday a German body published a study which says that the benefit of the company's product Alkindi over generic hydrocortisone has not been

Latest Share Chat

DNL.L Share News (DNL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Login to your account

Quickpicks are a member only feature

Login to your account